Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterActive in the last 2 years

Mashaal Dhir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1426-1098; OpenAlex author ID A5082911957. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 5

  1. Epithelial-Mesenchymal Transition Is Associated With Perineural Invasion in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.jss.2026.09.014↗
  2. MKI67 Enrichment Characterizes a Proliferative and Genomically Unstable Phenotype in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers18162631↗
  3. Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes. Co-author DOI 10.1007/s12029-025-01183-2↗
  4. Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates. Co-author DOI 10.1245/s10434-020-09474-7↗
  5. Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients. Co-author DOI 10.1186/s12957-017-1240-2↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Caleb Seavey · 2 shared papers, 2026 · strength 0.71
  2. Asama Khan · 2 shared papers, 2026 · strength 0.71
  3. Kazuaki Takabe · 2 shared papers, 2026 · strength 0.71
  4. Chandrakanth Are · 3 shared papers, 2017–2025 · strength 0.66
  5. Elizabeth Josephine Olecki · 1 shared paper, 2026 · strength 0.36
  6. Premila Devi Leiphrakpam · 1 shared paper, 2025 · strength 0.30
  7. Davendra P. S. Sohal · 1 shared paper, 2017 · strength 0.07
  8. Lynette M. Smith · 1 shared paper, 2017 · strength 0.07
  9. Eileen Mary O'Reilly · 1 shared paper, 2017 · strength 0.07
  10. Nathan Bahary · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.